Orientation to research is targeted at those new to the UK research enterprise but is open to all. It provides valuable information on support offices under the Office of the Vice President for Research, policies, procedures, and resources to help you expand your research.

Upcoming Proposal Development Office Presentation part of the Orientation to Research program.



December 12, 2022, at 3 pm: How to Read a Funding Opportunity

This presentation by Louetta K. Hurst will cover how to read a funding opportunity correctly to ensure it is a right fit for researchers.

Click the button below to request access to the SharePoint site to watch videos, participate in collaboration platforms, and view a calendar of in-person and virtual events.

FREE VIRTUAL EVENT!

Human Subjects Research:  Policies, Clinical Trials, & Inclusion

TODAY! Tuesday, December 6, 2022

12:00 PM - 4:00 PM ET 

Wednesday, December 7, 2022

12:00 PM - 4:00 PM ET



Over the course of two days, experts will be sharing HHS regulations, NIH policies and processes, as well as answering your questions. Through presentations, case studies, and Q&A, they hope to provide the guidance and resources you need in your role involving human subjects research. 

Human Subjects Protections, Inclusion, and Clinical Trials Resource Includes links to Policies, Notices, Tools, Resources, & Training on the following:

• Human Subjects Protections
• Clinical Trials
• Inclusion
• General Information

The Research Scholars Program (RSP) is a one-year, multicomponent career development program designed to promote research success for junior faculty, particularly those from groups underrepresented in biomedical and behavioral research (as defined by the National Institutes of Health (NIH; NOT-OD-20-031).

More details about the RSP can be found here. Program components include:

1. Several levels of mentorship, coaching, and sponsorship
2. Professional development programming
3. Inclusive networking by connecting to a larger supportive scientific and social community.

Two cohorts of Research Scholars have successfully completed the program thus far, see the website for details about the previous Research Scholars. This year, the program intends to recruit a cohort of up to six University of Kentucky (UK) faculty members from diverse disciplines across campus.

Eligibility criteria:

• U.S. citizen or permanent resident 
• Doctoral-level degree (MD, PhD, DMD, DDS, DO, PharmD)
• Full-time UK Regular Title Series or Research Title Series Assistant or Associate Professor
• Commitment of at least 30% effort to research
• Priority is given to investigators who have not yet achieved significant extramural funding as Principal Investigator

Nomination process: Nominations for the RSP must be submitted by the faculty member’s mentor, chair, dean, center director, or research supervisor. The attached document describes the process for nominations.

Due: Nominations will be accepted until January 13th, 2023.   

Questions? Please contact Dr. Nancy Schoenberg (nesch@uky.edu) or Dr. Kevin Pearson (kevin.pearson@uky.edu) for content questions and Jimmy Robinson (Jimmy.Robinson@uky.edu) for logistical questions. 

Purpose: Through the HEAL Initiative, NIH requests applications for studies designed to develop and test sustainable, scalable interventions to prevent opioid misuse, opioid use disorder, and co-occurring mental health conditions by intervening directly on social determinants of health (SDOH). This initiative aims to build an evidence base for preventive interventions that address inequities, social risks and/or social disadvantage. Interventions targeting social determinants may be structural (e.g. policy, regulatory, or systemic-wide changes) or designed to alter outcomes of individuals affected by contextual risk factors, and may be implemented in conjunction with psychosocial interventions designed to address behavioral risks.

Letter of Intent Due Date: January 2, 2023

Application Due Date: February 2, 2023

Agency: National Institute on Drug Abuse (NIDA)

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of substance using behaviors (defined as alcohol, tobacco, prescription, and other substances) and related disorders, prevention of substance use and HIV, and health service utilization. This FOA encourages the analyses of public use and other extant community-based or clinical datasets to their full potential in order to increase our knowledge of etiology, trajectories of substance using behaviors and their consequences including morbidity and mortality, risk and resilience in the development of psychopathology, strategies to guide the development, testing, implementation, and delivery of high quality, effective and efficient services for the prevention and treatment of substance use disorder and HIV. Primary data collection is not allowed for applications in response to this FOA.

Letter of Intent Due Date(s): 30 days prior to submission due date. See full announcement for an outlined of dates.

Agency: National Institute on Drug Abuse (NIDA)

Purpose: To invite applications proposing innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of substance using behaviors (defined as alcohol, tobacco, prescription, and other substances) and related disorders, prevention of substance use and HIV, and health service utilization. This FOA encourages the analyses of public use and other extant community-based or clinical datasets to their full potential in order to increase our knowledge of etiology, trajectories of substance using behaviors and their consequences including morbidity and mortality, risk and resilience in the development of psychopathology, strategies to guide the development, testing, implementation, and delivery of high quality, effective and efficient services for the prevention and treatment of substance use disorder and HIV. Primary data collection is not allowed for applications in response to this FOA.

Open Date (Earliest Submission Date): February 04, 2022

Letter of Intent Due Date(s): 30 days prior to application due date. See full announcement for an outlined of dates.

Agency: American Heart Association

Description: Funds highly innovative, high-impact projects that build on work in progress that could ultimately lead to critical discoveries or major advancements that will accelerate the AHA’s mission. Research deemed innovative may be built around an emerging paradigm, approaching an existing problem from a new perspective, or exhibit other uniquely creative qualities. Successful applications are likely to be those building on strong preliminary data supportive of the hypothesis.

Amount: $100,000 per year for 3 years

Closing Date: February 16, 2023

Description: This Funding Opportunity Announcement (FOA) invites applications that propose to develop novel research infrastructure that will advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations. This FOA utilizes NIH’s R61/R33 Exploratory/Developmental Phased Award activity code. The R61 phase provides up to 2 years of support for initial developmental activities. The R33 phase provides up to 3 years of support for expanded activities. Through this award, investigators will endeavor to develop a sustainable research infrastructure to support projects that address key interdisciplinary aging research questions.

Announcement Number: PAR-23-053

Closing Date: July 3, 2023